{"id":209860,"title":"Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population, CCDR 51(2/3) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T15:16:56.046000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2025-51/issue-2-3-february-march-2025/comparison-13-15-20-valent-pneumococcal-conjugate-vaccines-paediatric-canadian-population.html","snippet":"Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population, CCDR 51(2/3) - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main…","rawSnapshotUrl":"/api/snapshots/raw/209860","browseUrl":"https://replay.healtharchive.ca/job-1/20250418151656/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2025-51/issue-2-3-february-march-2025/comparison-13-15-20-valent-pneumococcal-conjugate-vaccines-paediatric-canadian-population.html#ha_snapshot=209860","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}